GSE204821
Rebalancing liver-infiltrated CCR3+ and CD206+ monocytes improves diet induced NAFLD
Melatonin has been reported to improve NAFLD, exploring the underlying mechanisms will be beneficial for better treatment of NAFLD. CDHFD- and MCD-fed mice with melatonin intervention exhibited significantly decreased liver steatosis, lobular inflammation, and focal liver necrosis. Single-cell RNA sequencing revealed melatonin selectively inhibited proinflammatory CCR3+ MoMFs, and upregulated anti-inflammatory CD206+ MoMFs in NAFLD mice. Hepatic infiltrated CCR3+CD14+ MoMFs is also significantly increased in patients with NAFLD. Mechanistically, melatonin receptor independent BTG2-ATF4 signaling plays a vital role in the regulation of CCR3+ MoMFs endoplasmic reticulum stress, survival, and proinflammation by melatonin. In contrast, melatonin upregulated CD206+ MoMFs survival and polarization via MT1/2 receptors. Melatonin stimulation also regulates human CCR3+ MoMFs and CD206+ MoMFs survival and inflammation in vitro. Furthermore, CCR3 depletion antibody monotherapy decreased liver inflammation and improved NAFLD in mice.  Thus, Therapies targeting CCR3+ MoMFs may have potential benefits in NAFLD treatment. Overall design: Mice were fed with either methionine/choline-deficient diet (MCD), or MCD diet with melatonin. 7AAD-CD45+Ly6G-CD11bintF4/80hi monocytes obtained from MCD-fed mice liver which was treated with or without melatonin, and each treatment was repeated twice.